Niagen Bioscience (NAGE) Depreciation and Depletion (2016 - 2026)
Niagen Bioscience has reported Depreciation and Depletion over the past 13 years, most recently at $139000.0 for Q4 2025.
- Quarterly Depreciation and Depletion fell 7.95% to $139000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $612000.0 through Dec 2025, down 7.69% year-over-year, with the annual reading at $612000.0 for FY2025, 7.69% down from the prior year.
- Depreciation and Depletion was $139000.0 for Q4 2025 at Niagen Bioscience, down from $157000.0 in the prior quarter.
- Over five years, Depreciation and Depletion peaked at $235000.0 in Q3 2022 and troughed at $139000.0 in Q4 2025.
- The 5-year median for Depreciation and Depletion is $206000.0 (2021), against an average of $195200.0.
- Year-over-year, Depreciation and Depletion rose 13.43% in 2023 and then decreased 29.61% in 2024.
- A 5-year view of Depreciation and Depletion shows it stood at $211000.0 in 2021, then rose by 4.74% to $221000.0 in 2022, then dropped by 19.91% to $177000.0 in 2023, then dropped by 14.69% to $151000.0 in 2024, then fell by 7.95% to $139000.0 in 2025.
- Per Business Quant, the three most recent readings for NAGE's Depreciation and Depletion are $139000.0 (Q4 2025), $157000.0 (Q3 2025), and $158000.0 (Q2 2025).